In this analysis of population-representative data on sharing clinical genetic test results, 90% of those who underwent high-risk cancer genetic testing (e.g., BRCA1/2 and Lynch syndrome) shared results with HCP/GCs, whereas only 68% shared results with their FDRs. The gene discussed is BRCA1; the disease is Lynch syndrome.